Acta Diabetologica
Bridging the gap in early cardio-renal risk prevention in type 2 diabetes: evidence, guidelines, and real-world insights from the PRECARE NO LiMITS initiative
By Loredana Bucciarelli, Maria Elena Lunati, C. Berra, Show 9 more authorson behalf of PRECARE NO LiMITS study group
Study in peopleInterventions
- GLP-1 receptor agonists
- SGLT2 inhibitors
- Type 2 diabetes
- Cardiovascular disease
- Chronic kidney disease
- Humans
